Chardan Capital Initiates Coverage On Prothena Corp With Buy Rating, Announces Price Target of $40

Benzinga3minutes ago · Ratings

Prothena Stock Soars Despite Study Miss

Investing03:28

Prothena Up Over 43%, On Pace for Largest Percent Increase Since September 2022 -- Data Talk

Dow Jones03:15

B of A Securities Maintains Neutral on Prothena Corp, Lowers Price Target to $22

Benzinga01:26 · Ratings

Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits

Benzinga00:31

Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday

BenzingaDec 19 23:49